HCV Rapid Antibody, In-home HIV, Advance HIV , and oral fluid lab HIV-1/2 test kits.

The Florida Department of Health's Bureau of Communicable Diseases is seeking to acquire specialized testing kits to enhance HIV and Hepatitis C screening efforts within high-risk communities across Florida. The procurement includes HCV Rapid Antibody test kits, in-home HIV testing kits utilizing oral fluid diagnostics, and rapid HIV-1/2 antibody test kits that deliver results within 20 minutes. These tests are essential for street outreach programs, enabling quick and accurate identification of HIV and Hepatitis C infections in populations that may not access traditional healthcare settings. All kits must be FDA approved and capable of providing clear positive or negative results rapidly, facilitating timely intervention and linkage to care. The contract is designated as a single-source purchase from OraSure, specifically for their HCV Rapid Antibody, in-home HIV OraQuick, and oral fluid lab HIV-1/2 test kits, in accordance with Florida Administrative Code Chapter 60A-1.045. The solicitation, titled "HCV Rapid Antibody, In-home HIV, Advance HIV, and oral fluid lab HIV-1/2 test kits," was posted on February 7, 2025, with responses due by February 13, 2025. The contract value is estimated between $500,000 and $2,000,000, and the project is managed by Yasemin Sulker, who can be contacted via email or phone for further details. This initiative aims to expand rapid testing accessibility, thereby improving early detection and treatment of HIV and Hepatitis C among vulnerable populations in Florida.